Last reviewed · How we verify

NCT04286984: IPAT

Implementation of a Patient Blood Management Program in Gastric Cancer Surgery

Completed Last updated 2 March 2020
What this trial tests

trial testing unified protocol of Patient Blood Management measure in Gastric Cancer in 1,063 participants. Completed in 31 December 2018.

Timeline
1 January 2014
Primary endpoint
31 December 2018
31 December 2018

Quick facts

Lead sponsorHospital Universitari de Bellvitge
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,063
Start date1 January 2014
Primary completion31 December 2018
Estimated completion31 December 2018

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Universitari de Bellvitge

Who can join

18 and older, any sex, with Gastric Cancer or Anemia, Iron Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective evaluation on a prospective cohort of patients undergoing curative gastric cancer resection to evaluate the impact of a patient blood management (PBM) program on transfusion rate and clinical outcomes. The study aims to compare transfusion practices and clinical outcomes of patients undergoing elective gastric cancer resection before and after implementing a PBM program, which included strategies to detect and treat preoperative anemia and restrictive transfusion practice (2014-2018). Primary outcome is transfusion rate (TR). Secondary outcomes are transfusion index (TI), postoperative complications, length of stay, 30-day readmissions, and 90-day mortality. Adherence to protocol is also analyzed. Differences of variables before and after PBM program implementation are evaluated with mean comparing analysis adjusted by confounding factors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of Perioperative Blood Transfusions and Infectious Complications on Inflammatory Activation and Long-Term Survival Following Gastric Cancer Resection.
    Puértolas N, Osorio J, Jericó C, Miranda C, et al · · 2022 · cited 10× · PMID 36612141 · DOI 10.3390/cancers15010144

Verify or expand the search:

Other recruiting trials for Gastric Cancer

Currently open trials in the same condition.

Other Hospital Universitari de Bellvitge trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04286984.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing